CSL Behring UK Limited Sustainability Profile
CSL Behring UK Limited, a subsidiary of the global biotechnology leader CSL Limited, is headquartered in Great Britain and operates extensively across Europe. Founded in 1904, CSL Behring has established itself as a pioneer in the biopharmaceutical industry, focusing on the development and manufacture of innovative therapies for rare and serious medical conditions. The company is renowned for its advanced therapies derived from human plasma, including immunoglobulins, clotting factors, and enzyme replacement therapies. These products are distinguished by their high quality and efficacy, addressing critical health needs for patients with conditions such as haemophilia and primary immunodeficiencies. With a strong market position, CSL Behring has achieved numerous accolades for its commitment to patient care and scientific excellence, solidifying its reputation as a trusted leader in the biopharmaceutical sector.
DitchCarbon Score
How does CSL Behring UK Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CSL Behring UK Limited's score of 46 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CSL Behring UK Limited, headquartered in Great Britain, currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of CSL Limited, which cascades its climate commitments and targets down to CSL Behring UK Limited. CSL Limited has made significant strides in addressing climate change, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for CSL Behring UK Limited have not been disclosed. As part of its corporate family, CSL Behring UK Limited aligns with the broader sustainability goals set by CSL Limited, focusing on reducing carbon emissions and enhancing environmental performance across its operations. The absence of direct emissions data highlights the need for ongoing transparency and commitment to climate action within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 250,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 58,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is CSL Behring UK Limited's Industry?
How Carbon Intensive is CSL Behring UK Limited's Location?
CSL Behring UK Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CSL Behring UK Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
